Metabolic Dysfunction-Associated Steatotic Liver Disease: Testing and Treatment

Did you know that Fatty Liver Disease is rapidly becoming the #1 cause of liver transplants worldwide? Dr. Nikhil Kapila breaks down the alarming rise of metabolic dysfunction-associated steatotic liver disease (MASLD) and why it’s no longer just a regional health issue. Understanding the risks starts with awareness. Read the full blog post on Fatty Liver Disease to learn more: https://go.flourishresearch.com/4aacVZj #LiverHealth #MASLD #HealthAwareness #FattyLiverDisease | Flourish Research - G

Nonalcoholic Steatohepatitis (NASH): Symptoms & Complications

NASH Treatment: Review Of Current And Future Therapies For Non-Alcoholic Steatohepatitis - PanNASH

NASH and nonalcoholic liver disease - SlideServe

Your Favorite Zero-Sugar Drinks May Be Silently Screwing With Your Liver

Metabolic dysfunction-associated steatotic liver disease (MASLD) aka “fatty liver disease” 1/3 of American adults have MASLD. >1/2 of adults with diabetes have MASLD. Screen for MASLD with labs (ALT, AST and platelets). Sometimes incidentally found on abdominal imaging obtained for other reasons. Calculate your FIB-4 score today at https://liver.org.au/health-professionals/fib-4-calculator/ | Lindsay Ogle

GoodFlip's Innovative Approach to Combat India's Silent Liver Disease Epidemic